Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery (NCT07723300) | Clinical Trial Compass
RecruitingNot Applicable
Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery
United States12 participantsStarted 2026-07
Plain-language summary
The goal of this clinical trial is to learn how a partially self-supervised constraint-induced movement therapy (sCIMT) program in adults with arm and hand weakness will work after stroke. This study will look at whether the program can help people improve the use of their arm and hand after a stroke while requiring less time with a therapist. The main questions it aims to answer are:
* Does the sCIMT program help people use their affected arm and hand better - after a stroke?
* Do participants feel that the sCIMT program is useful, easy to follow, and a good fit for their recovery needs?
* Does taking part in the sCIMT program improve participants' quality of life and daily well-being?
Participants will:
* Take part in a therapy program 5x/week for 2 weeks. The program is designed to help improve the use of the arm and hand affected by stroke.
* Wear a mitt on the stronger hand during certain practice activities to encourage use of the weaker hand.
* Complete surveys and tests before and after the program to measure arm and hand use, experiences with the program, and quality of life.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sustained a first-time ischemic or hemorrhagic stroke ≥2 weeks prior to study enrollment
* Age ≥18 and ≤85
* Moderate UE hemiparesis as defined by a score ≥13 and ≤47 on the modified UE section of the Fugl-Meyer Assessment (60-point scale with no reflex testing)
* Ability to actively extend impaired wrist ≥10 degrees
* UE strength and active range of motion within functional limits on the non-hemiparetic side
* Ability to follow two-step commands (visual or verbal) as determined by the clinical investigator
* Nonuse of the more impaired UE as evidenced by an average score ≤2.5 on the Motor Activity Log Amount of Use Scale.
Exclusion Criteria:
* Excessive pain in the affected shoulder, arm, or hand as measured by a score ≥6 on a 10-point visual analogue scale
* Unable to passively reach neutral position for wrist extension and forearm supination
* Excessive spasticity in the affected wrist or finger flexors/extensors and elbow flexors, as defined as a score of \>2 on the Modified Ashworth Scale (MAS)
* Inability to actively participate in regular therapy sessions (e.g., due to medical complexity, insufficient endurance, transportation, etc.) as determined by participant or by clinical judgement of the evaluating therapist
* Receiving occupational therapy services for the hemiparetic UE during the two-week intervention window (including after pre-assessment and before post-assessment)
* Received focal anti-spasticity drug injection (e.g., Botox) to any …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Action Research Arm Test (ARAT) Score from Baseline to Post-Intervention
Timeframe: Baseline and post-intervention (within 1 week of completing the 2-week sCIMT program)
2
Implementation of sCIMT (AIM, FIM, IAM Score)
Timeframe: Post-intervention (within 1 week of completing the 2-week sCIMT program)